Peanut oral immunotherapy involves consuming small but increasing amounts of peanut over time to help build tolerance. The study is using an anti-allergy medication (omalizumab) together with peanut oral immunotherapy (also known as desensitisation), to understand whether peanut immunotherapy will be safer, quicker and more tolerable.

Please note all study visits will be conducted at St Vincent's Hospital in Sydney.

For more information and to register your interest please contact the St Vincent's Hospital team via email: This email address is being protected from spambots. You need JavaScript enabled to view it.